Logo image of ILLR

TRILLER GROUP INC (ILLR) Stock Fundamental Analysis

NASDAQ:ILLR - Nasdaq - US8959701017 - Common Stock - Currency: USD

0.74  +0.07 (+10.45%)

After market: 0.7376 0 (-0.32%)

Fundamental Rating

1

Overall ILLR gets a fundamental rating of 1 out of 10. We evaluated ILLR against 99 industry peers in the Financial Services industry. Both the profitability and financial health of ILLR have multiple concerns. ILLR is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year ILLR has reported negative net income.
ILLR had a negative operating cash flow in the past year.
ILLR Yearly Net Income VS EBIT VS OCF VS FCFILLR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 50M

1.2 Ratios

ILLR has a worse Return On Assets (-44.05%) than 94.95% of its industry peers.
Industry RankSector Rank
ROA -44.05%
ROE N/A
ROIC N/A
ROA(3y)-13.05%
ROA(5y)N/A
ROE(3y)-503.13%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ILLR Yearly ROA, ROE, ROICILLR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 200 -200 -400 -600 -800 -1K

1.3 Margins

The Gross Margin of ILLR (45.05%) is better than 65.66% of its industry peers.
ILLR's Gross Margin has declined in the last couple of years.
ILLR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 45.05%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-22.38%
GM growth 5YN/A
ILLR Yearly Profit, Operating, Gross MarginsILLR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 200 400 600 800

More info and screens

0

2. Health

2.1 Basic Checks

ILLR does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ILLR has less shares outstanding
ILLR has a worse debt/assets ratio than last year.
ILLR Yearly Shares OutstandingILLR Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 10M 20M 30M 40M 50M
ILLR Yearly Total Debt VS Total AssetsILLR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 50M 100M 150M

2.2 Solvency

Based on the Altman-Z score of -1.88, we must say that ILLR is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -1.88, ILLR is doing worse than 73.74% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -1.88
ROIC/WACCN/A
WACC9.1%
ILLR Yearly LT Debt VS Equity VS FCFILLR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 50M 100M

2.3 Liquidity

ILLR has a Current Ratio of 0.56. This is a bad value and indicates that ILLR is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of ILLR (0.56) is worse than 64.65% of its industry peers.
A Quick Ratio of 0.56 indicates that ILLR may have some problems paying its short term obligations.
ILLR has a worse Quick ratio (0.56) than 64.65% of its industry peers.
Industry RankSector Rank
Current Ratio 0.56
Quick Ratio 0.56
ILLR Yearly Current Assets VS Current LiabilitesILLR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 20M 40M 60M 80M

More info and screens

3

3. Growth

3.1 Past

ILLR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -97.13%.
Looking at the last year, ILLR shows a very strong growth in Revenue. The Revenue has grown by 74.35%.
Measured over the past years, ILLR shows a very strong growth in Revenue. The Revenue has been growing by 56.82% on average per year.
EPS 1Y (TTM)-97.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-52.63%
Revenue 1Y (TTM)74.35%
Revenue growth 3Y56.82%
Revenue growth 5YN/A
Sales Q2Q%-58.82%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ILLR Yearly Revenue VS EstimatesILLR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 10M 20M 30M 40M 50M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

ILLR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ILLR Price Earnings VS Forward Price EarningsILLR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ILLR Per share dataILLR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4 -0.6 -0.8 -1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ILLR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

TRILLER GROUP INC

NASDAQ:ILLR (6/18/2025, 8:00:01 PM)

After market: 0.7376 0 (-0.32%)

0.74

+0.07 (+10.45%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)08-09 2024-08-09/amc
Earnings (Next)N/A N/A
Inst Owners1.7%
Inst Owner Change261.7%
Ins Owners17.75%
Ins Owner Change0%
Market Cap129.76M
AnalystsN/A
Price TargetN/A
Short Float %1.32%
Short Ratio2.47
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 4.25
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.03
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.17
FCFYN/A
OCF(TTM)-0.17
OCFYN/A
SpS0.17
BVpS-0.03
TBVpS-0.03
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -44.05%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 45.05%
FCFM N/A
ROA(3y)-13.05%
ROA(5y)N/A
ROE(3y)-503.13%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-22.38%
GM growth 5YN/A
F-Score5
Asset Turnover0.32
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.56
Quick Ratio 0.56
Altman-Z -1.88
F-Score5
WACC9.1%
ROIC/WACCN/A
Cap/Depr(3y)96.29%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.1%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-97.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-52.63%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)74.35%
Revenue growth 3Y56.82%
Revenue growth 5YN/A
Sales Q2Q%-58.82%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-52.64%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-109.11%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-119.08%
OCF growth 3YN/A
OCF growth 5YN/A